Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-284046
Filing Date
2024-12-23
Accepted
2024-12-23 14:08:25
Documents
4
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 6-K d915699d6k.htm 6-K 9050
2 EX-99.1 d915699dex991.htm EX-99.1 9850
3 EX-99.2 d915699dex992.htm EX-99.2 15939
4 GRAPHIC g915699g1223224559421.jpg GRAPHIC 2601
  Complete submission text file 0001193125-24-284046.txt   39785
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241572423
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)